HomeTagsTMX Group

Tag: TMX Group

Business

TMX Group Completes Acquisition of Cboe Australia

New subsidiary will be rebranded TMX Australia Exchange TMX Group Limited (TMX Group) announced today it has completed the acquisition of Middlebury Holdings Pty. Limited...

Business

Toronto Stock Exchange Unveils the 2024 TSX30, Recognizing the Companies Powering Canada’s Economy

Annual ranking highlights top-performing stocks' roles in energy security and electrification, and a shift from growth to value investing Toronto Stock Exchange (TSX) today announced...

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Business

GMG Announces Updated Battery Brand

Business

White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold...

Medical

Micot Pharma’s MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

Business

Tag: TMX Group

GMG Announces Updated Battery Brand

White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold...

Micot Pharma’s MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

Truecaller Ads Launches ‘Truecaller Pulse’; An Industry First Declared Intent Media Solution

Latest

GMG Announces Updated Battery Brand

White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold...

Micot Pharma’s MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

Popular

GMG Announces Updated Battery Brand

White Gold Corp. Announces Positive Preliminary Economic Assessment with C$1.9 Billion After-Tax NPV, 38% IRR and 1.7 Year Payback Period on the White Gold...

Micot Pharma’s MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

Sitemap